Popular Content
Featured Articles





View Full Article

Catching Your Breath: Managing COPD Exacerbations 7/17/2014

Chronic obstructive pulmonary disease is an inflammatory disease of the lung characterized by progressive airflow limitation that is not fully reversible.
View Full Article

Deep Venous Thrombosis: The “Economy Class Syndrome” 7/17/2014

DVT should be treated using anticoagulant and possibly thrombolytic therapy.
View Full Article

Diabetic Peripheral Neuropathy 7/17/2014

Diabetic peripheral neuropathy is present in up to 10% of type 2 diabetes mellitus patients upon initial diagnosis.
View Full Article

Influenza: Optimizing Prevention and Treatment Strategies 7/17/2014

Seasonal influenza causes significant respiratory illness, resulting in approximately 25,000 deaths in the United States each year.
View Full Article

Prevention and Management of Respiratory Viruses 7/17/2014

Pharmacists are in a key position to ensure that appropriate infection control measures are followed.
View Full Article

Respiratory Syncytial Virus: Diagnosis, Prevention, and Management of Complications 7/17/2014

Respiratory syncytial virus, a common childhood viral illness, is a seasonal infection, with the highest rates occurring in the United States in the fall and winter (between November and March).
View Full Article

Update on the Management of Pediatric Acute Otitis Media 7/17/2014

New clinical practice guidelines for treating ear infections were recently released.

Corns and Calluses: Overview of Common Keratotic Lesions 6/19/2014

If the condition is sufficiently severe, the patient’s gait and choice of activities or footwear may be affected.

Management of Acute Diabetic Foot Disease 6/19/2014

Diabetic foot disease is a spectrum of disorders involving the cutaneous, soft-tissue, and osseous structures of the foot.

New Cholesterol Treatment Guideline: Implications for Pharmacy Practice 6/19/2014

The 2013 American College of Cardiology/American Heart Association Guideline on the Treatment of Blood Cholesterol takes an evidence-based approach that stresses the reduction of cardiovascular risk.

Onychomycosis: Clinical Considerations and Recommendations 6/19/2014

Often viewed as a purely cosmetic issue, nail fungus may lead to complications and should be treated.


Congenital and Acquired Long QT Syndrome: A Pharmacist’s Perspective 5/16/2014

Long QT syndrome, a heart condition in which cardiac repolarization is delayed following a heartbeat, can be detected by measuring the QT interval on an ECG.

Pediatric Idiopathic Nephrotic Syndrome 5/16/2014

Pediatric patients with nephrotic syndrome have increased glomerular filtration barrier permeability, resulting in clinical features such as proteinuria, hypoalbuminemia, edema, and dyslipidemia.

Screening and Treatment of Pediatric Dyslipidemias 5/16/2014

Universal screening is recommended regardless of family history or risk factors.


The Role of Probiotics in Children With Gastrointestinal Disease 5/16/2014

Probiotics are active living microorganisms that have a defined health benefit—either therapeutic or preventive—when ingested in sufficient quantity.1

Transitions of Care: Pharmacist Collaboration at a Community Teaching Hospital 5/16/2014

Pharmacists are involved in strategies to reduce readmissions and improve patient outcomes.


Varicella-Zoster Virus Infection in Children and Adolescents 5/16/2014

Routine vaccination has been very effective in reducing the incidence of chickenpox.


Acute Pericarditis Treatment: Update on Colchicine 4/18/2014

Acute pericarditis (inflammation of the pericardial sac) is the most common pericardial disease, accounting for 5% of emergency department admissions in patients presenting with nonischemic chest pain.

Anaphylaxis, Epinephrine Auto-Injectors, and Importance of the BX Rating 4/18/2014

EAIs are the current recommended first-line treatment for patients at risk for anaphylaxis, and it is critical that patients be properly trained on their device.


Management of Hepatitis C Genotype 1 Monoinfection 4/18/2014

HCV genotype 1, which is the most common cause of hepatitis C infection in the U.S., is the most difficult form to treat.
For more articles, please check our archives.
Advertisement